Fukoku Mutual Life Insurance CO Dexcom Inc Transaction History

Fukoku Mutual Life Insurance CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$110.31 - $140.45 $22,613 - $28,792	-205 Reduced 8.0%	2,357 $267,000
Q4 2022 Jan 31, 2023	SELL	$84.98 - $122.67 $122,201 - $176,399	-1,438 Reduced 35.95%	2,562 $290,000
Q3 2022 Nov 02, 2022	BUY	$76.35 - $94.18 $51,917 - $64,042	680 Added 20.48%	4,000 $322,000
Q2 2022 Jul 29, 2022	BUY	$67.99 - $132.89 $169,295 - $330,896	2,490 Added 300.0%	3,320 $247,000
Q4 2021 Jan 25, 2022	BUY	$129.87 - $162.82 $12,987 - $16,282	100 Added 13.7%	830 $446,000
Q3 2021 Nov 09, 2021	BUY	$106.71 - $143.18 $13,872 - $18,613	130 Added 21.67%	730 $399,000
Q4 2020 Jan 27, 2021	BUY	$78.0 - $104.5 $46,800 - $62,700	600 New	600 $222,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Fukoku Mutual Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Fukoku Mutual Life Insurance CO with notifications on news.